About Sino Biopharmaceut (OTCMKTS:SBMFF)
Sino Biopharmaceutical Limited, researches, develops, manufactures, and markets Chinese medicines and chemical medicines in Hong Kong. The company operates through three segments: Modernized Chinese Medicines and Chemical Medicines, Investment, and Others. Its principal products include hepatitis medicines, such as Tianqingganmei injections, Runzhong dispersible tablets, Mingzheng capsules, Tianqingganping enteric capsules, and Ganlixin injections and capsules; and cardio-cerebral medicines comprising Yilunping and Tuotuo tablets, as well as Tianqingning injections; and oncology medicines consisting of Zhiruo, Saiweijian, and Tianqingyitai injections. The company's principal products also include Orthopedic medicines, which comprise New Ossified Triol capsules and Jiuli tablets; anti-infectious medicines, including Tiance injections; parenteral nutritious medicines, such as Xinhaineng and Fenghaineng fructose injections; respiratory system medicines, including Tianqingsule inhalation powder and Chia Tai Suke tablets; and anorectal medicines comprising Getai tablets. In addition, it develops medicines for treating tumors, analgesia, diabetes, and other diseases; engages in the retail of pharmaceutical products; provides medical management consultancy services; and manufactures, sells, and distributes health food products, as well as is involved in optometry for optical glasses and sale of ophthalmic products. Further, the company provides research and development services; and operates Chia Tai Shaoyang Orthopedic Hospital. Sino Biopharmaceutical Limited was incorporated in 2000 and is headquartered in Wanchai, Hong Kong.
Industry, Sector and Symbol
Industry Private households
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:SBMFF
CUSIPN/A
Phone852-2802-9886
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E Ratio71.63
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$2.04 billion
Price / Sales8.88
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees18,163
Outstanding Shares8,425,190,000
Sino Biopharmaceut (OTCMKTS:SBMFF) Frequently Asked Questions
What is Sino Biopharmaceut's stock symbol?
Sino Biopharmaceut trades on the OTCMKTS under the ticker symbol "SBMFF."
When is Sino Biopharmaceut's next earnings date?
Who are some of Sino Biopharmaceut's key competitors?
Some companies that are related to Sino Biopharmaceut include BMW (BAMXF), Heineken International (HEINY), Vinci (VCISY), Nintendo (NTDOY), Deutsche Post (DPSGY), Lukoil (LUKOY), Schneider Electric (SBGSY), Japan Tobacco (JAPAY), China Shenhua Energy (CSUAY), UniCredit (UNCFF), Iberdrola (IBDRY), CK Hutchison (CKHUY), Sun Hung Kai Properties (SUHJY), Sands China (SCHYY) and Bank of China (BACHY).
Who are Sino Biopharmaceut's key executives?
Sino Biopharmaceut's management team includes the folowing people:
- Miss Y. Y. Tse, Chairlady (Age 25)
- Mr. Ping Tse, Founder, CEO, Pres, Compliance Officer & Exec. Director (Age 66)
- Mr. Zhoushan Tian, Exec. Director (Age 54)
- Mr. Shanchun Wang, Exec. Director (Age 50)
- Ms. Mingqin Li, VP & Exec. Director (Age 59)
Has Sino Biopharmaceut been receiving favorable news coverage?
News coverage about SBMFF stock has been trending somewhat positive on Thursday, Accern reports. The research group identifies positive and negative media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Sino Biopharmaceut earned a media sentiment score of 0.11 on Accern's scale. They also assigned news stories about the company an impact score of 47.48 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near term.
How do I buy shares of Sino Biopharmaceut?
Shares of SBMFF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Sino Biopharmaceut's stock price today?
One share of SBMFF stock can currently be purchased for approximately $2.15.
How big of a company is Sino Biopharmaceut?
Sino Biopharmaceut has a market capitalization of $16.85 billion and generates $2.04 billion in revenue each year. Sino Biopharmaceut employs 18,163 workers across the globe.
How can I contact Sino Biopharmaceut?
Sino Biopharmaceut's mailing address is Rm 4109 Office Tower Convention Plaza 1 Harbour Road Wanchai, Hong Kong K3, . The company can be reached via phone at 852-2802-9886 or via email at [email protected]
MarketBeat Community Rating for Sino Biopharmaceut (SBMFF)
MarketBeat's community ratings are surveys of what our community members think about Sino Biopharmaceut and other stocks. Vote "Outperform" if you believe SBMFF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SBMFF will underperform the S&P 500 over the long term. You may vote once every thirty days.
Sino Biopharmaceut (OTCMKTS:SBMFF) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | N/A | Sell | Sell | Sell |
| Consensus Rating Score: | N/A | 1.00 | 1.00 | 1.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | N/A | N/A | N/A | N/A |
| Price Target Upside: | N/A | N/A | N/A | N/A |
Sino Biopharmaceut (OTCMKTS:SBMFF) Consensus Price Target History
Sino Biopharmaceut (OTCMKTS:SBMFF) Analyst Ratings History
Show:
| Date | Brokerage | Action | Rating | Price Target | Details |
|---|
| 4/18/2017 | Jefferies Group | Initiated Coverage | Underperform | |  |
(Data available from 4/26/2016 forward)
Sino Biopharmaceut (OTCMKTS:SBMFF) Earnings History and Estimates Chart
Sino Biopharmaceut (OTCMKTS SBMFF) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 5/25/2018 | | | | | | | | |
| 5/26/2017 | Q1 2017 | | $0.01 | | $560.75 million | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
Sino Biopharmaceut (OTCMKTS:SBMFF) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Sino Biopharmaceut (OTCMKTS SBMFF) Insider Trading and Institutional Ownership History
Sino Biopharmaceut (OTCMKTS SBMFF) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
(Data available from 1/1/2013 forward)
Sino Biopharmaceut (OTCMKTS SBMFF) News Headlines
| Source: |
|
Sino Biopharmaceut (OTCMKTS:SBMFF) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Sino Biopharmaceut (OTCMKTS SBMFF) Stock Chart for Thursday, April, 26, 2018
Loading chart…
